Some biomarkers are over-expressed on tumor surface not on normal cells, such as HER2, EpCAM, folate receptor, epidermal growth factor receptor (EGFR) and so on, which were usually used as the tumor targets. This evidence concerns the gene EGFR and neoplasm.